Organization | MPI Research

MPI Research Report issue

For profit Phase 1 Phase 4

Founded: Mattawan MI United States (1995)

Status: Acquired by Charles River (2018)

Organization Overview

First Clinical Trial

None

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

None

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (3)

Key: MPI Research (0) Acquired (3)

hyaluronidase (human recombinant) (Hylenex) (1 trial)

nelfinavir (viracept) (1 trial)

omeprazole (prilosec) (1 trial)

Drugs in Phase 1 Trials (11)

Key: MPI Research (0) Acquired (11)

card-024 (1 trial)

cxa-10 (3 trials)

edetic acid (1 trial)

ezetimibe (zetia) (1 trial)

medium chain triglyceride (1 trial)

plazomicin (Zemdri) (1 trial)

pravastatin (pravachol) (1 trial)

simvastatin (zocor) (1 trial)

soybean oil (Intralipid) (1 trial)

sucrose (1 trial)

Indications

Overview

Highest Phase: None
# of Trials: 8
# of Trial APIs: 14